Continuous Glucose Monitoring Versus Capillary Point-of-Care Testing for Inpatient Glycemic Control in Type 2 Diabetes Patients Hospitalized in the General Ward and Treated With a Basal Bolus Insulin Regimen.

Autor:	Gómez AM; Pontificia Universidad Javeriana, Bogotá, Colombia Hospital Universitario San Ignacio, Bogotá, Colombia., Umpierrez GE; Department of Medicine, Emory University, Atlanta, GA, USA Division of Endocrinology, Metabolism and Lipids, Emory University, Atlanta, GA, USA., Muñoz OM; Pontificia Universidad Javeriana, Bogotá, Colombia Hospital Universitario San Ignacio, Bogotá, Colombia Department of Internal Medicine, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá, Colombia o.munoz@javeriana.edu.co., Herrera F; Pontificia Universidad Javeriana, Bogotá, Colombia Hospital Universitario San Ignacio, Bogotá, Colombia., Rubio C; Hospital Universitario San Ignacio, Bogotá, Colombia Clínica La Colina, Bogotá, Colombia., Aschner P; Pontificia Universidad Javeriana, Bogotá, Colombia Hospital Universitario San Ignacio, Bogotá, Colombia Endocrinology Unit, Department of Internal Medicine, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá, Colombia., Buendia R; Endocrinology Unit, Department of Internal Medicine, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá, Colombia.
Jazyk:	angličtina
Zdroj:	Journal of diabetes science and technology [J Diabetes Sci Technol] 2015 Aug 31; Vol. 10 (2), pp. 325-9. Date of Electronic Publication: 2015 Aug 31.
DOI:	10.1177/1932296815602905
Abstrakt:	Background: Continuous glucose monitoring (CGM) may improve the management of patients with type 2 diabetes hospitalized in the general ward by facilitating the detection of hyper- and hypoglycemic episodes. However, the lack of data on the accuracy and safety of CGM have limited its application. Methods: A prospective pilot study was conducted including 38 patients hospitalized in the general ward with a known diagnosis of type 2 diabetes mellitus (DM) and hyperglycemic individuals without a history of DM with a blood sugar of 140-400 mg on admission treated with a basal bolus insulin regimen. Inpatient glycemic control and the incidence of hypoglycemic episodes were compared between detection by CGM of interstitial fluid for up to 6 days and point-of-care (POC) capillary blood glucose monitoring performed pre- and postprandially, before bedtime and at 3 am. Results: No differences in average daily glucose levels were observed between CGM and POC (176.2 ± 33.9 vs 176.6 ± 33.7 mg/dl, P = .828). However, CGM detected a higher number of hypoglycemic episodes than POC (55 vs 12, P < .01). Glucose measurements were clinically valid, with 91.9% of patients falling within the Clarke error grid A and B zones. Conclusions: Our preliminary results indicate that the use of CGM in type 2 patients hospitalized in the general ward provides accurate estimation of blood sugar levels and is more effective than POC for the detection of hypoglycemic episodes and asymptomatic hypoglycemia. (© 2015 Diabetes Technology Society.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu